Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR – Get Free Report) and Tilray (NASDAQ:TLRY – Get Free Report) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.
Analyst Ratings
This is a summary of current ratings for Synergy CHC Corp. (Uplisting) and Tilray, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Synergy CHC Corp. (Uplisting) | 0 | 0 | 1 | 1 | 3.50 |
Tilray | 0 | 3 | 2 | 0 | 2.40 |
Synergy CHC Corp. (Uplisting) presently has a consensus price target of $10.00, indicating a potential upside of 214.47%. Tilray has a consensus price target of $2.70, indicating a potential upside of 320.43%. Given Tilray’s higher probable upside, analysts plainly believe Tilray is more favorable than Synergy CHC Corp. (Uplisting).
Insider & Institutional Ownership
Profitability
This table compares Synergy CHC Corp. (Uplisting) and Tilray’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Synergy CHC Corp. (Uplisting) | N/A | N/A | N/A |
Tilray | -30.95% | -4.40% | -3.57% |
Earnings and Valuation
This table compares Synergy CHC Corp. (Uplisting) and Tilray”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Synergy CHC Corp. (Uplisting) | $26.01 million | 1.06 | N/A | N/A | N/A |
Tilray | $210.48 million | 2.86 | -$244.98 million | ($0.30) | -2.14 |
Synergy CHC Corp. (Uplisting) has higher earnings, but lower revenue than Tilray.
Summary
Tilray beats Synergy CHC Corp. (Uplisting) on 6 of the 11 factors compared between the two stocks.
About Synergy CHC Corp. (Uplisting)
Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.
About Tilray
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
Receive News & Ratings for Synergy CHC Corp. (Uplisting) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synergy CHC Corp. (Uplisting) and related companies with MarketBeat.com's FREE daily email newsletter.